Oxybutynin Chloride
Product Images NDC 54868-5743

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 54868-5743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Figure 1. Mean R-oxybutynin Graph (Figure 1 Graph)

A line graph comparing mean R-enantiomer concentrations (ng/mL) over 24 hours for Oxybutynin Chloride Extended Release 10 mg once daily (QD) and Oxybutynin 5 mg three times daily (TID). The x-axis is time in hours, and the y-axis is concentration. The graph includes error bars for variability.*

FDA Label Image

Image Of Figure 2. Mean Steady State Graph (Figure 2 Graph)

A line graph depicting mean plasma concentration of beta-Oxybutynin over time in hours, ranging from 0 to 24 hours on the x-axis and concentration in ng/mL from 0.0 to 2.0 on the y-axis. The data points show an initial increase in concentration, peaking around 5 hours, followed by a gradual decline with error bars indicating variability.*

FDA Label Image

Image Of Oxybutynin Chloride Chemical Structure (Oxybutynin Chloride Chemical Structure)

Chemical structure diagram showing the molecular formula of oxybutynin hydrochloride, the active ingredient in Oxybutynin Chloride. The diagram features various chemical bonds and rings characteristic of this compound.*

FDA Label Image

Image Of Package Label (Package Label)

Oxybutynin Chloride extended-release tablets, 15 mg strength, labeled under Physicians Total Care, Inc. The label indicates a quantity of 30 tablets per container and includes dosage information. It also features warnings, storage instructions, and lot and expiration dates.*

FDA Label Image

Image Of Study 1 (Study 1)

A table and associated forest plot showing the number of urge urinary incontinence episodes per week from a clinical study comparing Oxybutynin Chloride Extended Release Tablets versus placebo. The table includes sample sizes, mean baseline episodes, mean change from baseline with standard deviations, and 95% confidence intervals. The forest plot illustrates the mean change in episodes per week from baseline, with confidence intervals indicating statistical significance favoring Oxybutynin Chloride Extended Release Tablets.*

FDA Label Image

Image Of Study 2 (Study 2)

A data table presenting study results comparing oxybutynin chloride extended release tablets to oxybutynin. It includes mean baseline values, mean change from baseline with standard deviation, and 95% confidence intervals for the difference between treatments. Below the table is a bar chart visualizing these differences.*

FDA Label Image

Image Of Study 3 (Study 3)

A data table comparing the mean baseline, mean change from baseline, and 95% confidence interval for difference in study 3 between Oxybutynin Chloride extended release tablets and a comparator. The data includes subject numbers and confidence intervals with statistical annotations, accompanied by a horizontal error bar plot illustrating differences in response rates with standard deviations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.